Quality and Innovation Bringing Drug Discovery Back to the United States
Outsourcing is no longer just about cost reduction. The desire for efficiency that prompted pharmaceutical and biotechnology sponsors to externalize research decades ago is now focused on services firms, which are responding by developing smarter ways of working.
More efficient drug discovery is existential. Pharmaceutical companies struggling to develop new products in a cost effective manner are attracted to contract research organizations (CROs) that can find the best drug candidates more quickly and efficiently.
As a result, U.S. CROs with broad expertise, access to talented biology and chemistry workforce, and the ability to streamline the discovery process are winning back business lost to volume-focused overseas rivals.
In addition, demand for high-quality data and the growing recognition of the benefits of working with full-service providers based in the same region is seeing more pharmaceutical companies outsource drug discovery work to U.S. CROs.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.